technetium tc 99m dimercaptosuccinic acid has been researched along with Astrocytoma, Grade IV in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Hadi, E; Amin, A; Badwey, A; Monier, A; Mustafa, M; Saad, E | 1 |
| Denoyer, D; Dubois, F; Frere, D; Le Jeune, N; Perek, N | 1 |
| Bin, V; Dubois, F; Le Jeune, N; Perek, N | 1 |
| Dubois, F; Le Jeune, N; Perek, N | 1 |
| Chatzipanagiotou, T; Papantoniou, V; Pirmettis, I; Ptohis, N; Tsiouris, S | 1 |
| Endo, K; Hirano, T; Otake, H; Shibasaki, T; Tamura, M | 1 |
6 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Tomography, Emission-Computed, Single-Photon | 2015 |
Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Hydrogen-Ion Concentration; Kinetics; Metabolic Clearance Rate; Neoplasms; Osteosarcoma; Phosphates; Phosphorus Radioisotopes; Potassium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sodium; Sodium-Phosphate Cotransporter Proteins; Sodium-Phosphate Cotransporter Proteins, Type I; Symporters; Technetium Tc 99m Dimercaptosuccinic Acid | 2004 |
Evaluation of imatinib mesylate effects on glioblastoma aggressiveness with SPECT radiotracer 99mTc-(v)-DMSA.
Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiopharmaceuticals; Receptors, Platelet-Derived Growth Factor; Technetium Tc 99m Dimercaptosuccinic Acid; Tomography, Emission-Computed, Single-Photon | 2006 |
Influence of Pi3-K and PKC activity on 99mTc-(V)-DMSA uptake: correlation with tumour aggressiveness in an in vitro malignant glioblastoma cell line model.
Topics: Cell Line, Tumor; Enzyme Activation; Glioblastoma; Humans; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Protein Kinase C; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic; Technetium Tc 99m Dimercaptosuccinic Acid | 2006 |
Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.
Topics: Adult; Antineoplastic Agents; Benzamides; Brain; Brain Neoplasms; Cell Proliferation; Fatal Outcome; Glioblastoma; Humans; Imatinib Mesylate; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2007 |
Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Child; Female; Glioblastoma; Glioma; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Oligodendroglioma; Organotechnetium Compounds; Radionuclide Imaging; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid | 1997 |